The company's purpose is to conduct research in the field of personalized medicine and develop digital solutions in the field of neuroscience for internal and external use. The company may also participate in, found, acquire, and merge with other companies of any kind, both domestically and abroad. It may acquire, encumber, and dispose of real estate and intellectual property rights, both domestically and abroad, and establish branches and agencies domestically and abroad by resolution of the management. The company may grant loans or other financing to its direct or indirect parent companies and their direct or indirect subsidiaries, and provide collateral of any kind for the liabilities of such other companies, including by way of pledges or fiduciary transfers of the company's assets or guarantees of any kind.